Cytomegalovirus High-risk Kidney Transplant Recipients Show No Difference in Long-term Outcomes Following Preemptive Versus Prophylactic Management

Following kidney transplantation (KT), cytomegalovirus (CMV) infection remains an important challenge. Both prophylactic and preemptive antiviral protocols are used for CMV high-risk kidney recipients (donor seropositive/recipient seronegative; D+/R-). We performed a nationwide comparison of the 2 s...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Transplantation 2023-08, Vol.107 (8), p.1846-1853
Hauptverfasser:	Blom, Kjersti B., Birkeland, Grete K., Midtvedt, Karsten, Jenssen, Trond G., Reisæter, Anna V., Rollag, Halvor, Hartmann, Anders, Sagedal, Solbjørg, Sjaastad, Ivar, Tylden, Garth, Njølstad, Gro, Nilsen, Einar, Christensen, Andreas, Åsberg, Anders, Birkeland, Jon A.
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Antiviral Agents - therapeutic use Cytomegalovirus Cytomegalovirus Infections - diagnosis Cytomegalovirus Infections - drug therapy Cytomegalovirus Infections - prevention & control Ganciclovir - therapeutic use Humans Kidney Transplantation - adverse effects Original Clinical Science—General Retrospective Studies Transplant Recipients
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!